Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: Stephen Locarnini Clear advanced filters

  • A new study has found undetectable serum levels of HBV DNA at week 24 of treatment to be the strongest predictor of optimal outcomes for patients with chronic HBV infection. Although this finding is not surprising, it has important implications for those patients on antiviral therapy who do not achieve a favorable response.

    • Tin Nguyen
    • Stephen Locarnini
    News & Views
    Nature Reviews Gastroenterology & Hepatology
    Volume: 6, P: 565-567

  • The many gaps in our knowledge and understanding of HBV infection hampers our ability to develop and achieve a cure on a global scale. In this Perspective, Fabien Zoulim and colleagues propose the development of an international group consisting of four working groups (virology, immunology, innovative tools and clinical trials) to tackle the big questions and make important steps towards eradicating this disease.

    • Peter Revill
    • Barbara Testoni
    • Fabien Zoulim
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 13, P: 239-248

  • Hepatitis B virus is a human hepatotropic DNA virus that can cause a lifelong chronic infection and progressive liver disease. This Primer discusses the epidemiology, mechanisms, diagnosis, prevention and management of chronic hepatitis B virus infection.

    • Man-Fung Yuen
    • Ding-Shinn Chen
    • Ching-Lung Lai
    Reviews
    Nature Reviews Disease Primers
    Volume: 4, P: 1-20

  • Hepatitis B virus (HBV) infection remains a global public health issue. This Review provides insights into the evolution of HBV and discusses the mechanisms by which HBV and hepatitis delta virus diversity occurs and the influence of this diversity on disease progression and treatment response.

    • Peter A. Revill
    • Thomas Tu
    • Margaret Littlejohn
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 17, P: 618-634